SCHEMBL30363327

SCHEMBL30363327

CSC1=N/C(=C\c2ccc3cnncc3c2)C(=O)N1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.63
▸ GAA P10253 2/20 0.63
▸ DYRK3 O43781 5/20 0.60
▸ PIM1 P11309 5/20 0.60
▸ CSNK2A2 P19784 5/20 0.60
▸ CSNK2B P67870 5/20 0.60
▸ CSNK2A1 P68400 5/20 0.60
▸ DYRK1A Q13627 5/20 0.60
▸ CSNK2A3 Q8NEV1 5/20 0.60
▸ DYRK2 Q92630 5/20 0.60
▸ DYRK1B Q9Y463 5/20 0.60
▸ HPGD P15428 2/20 0.60
▸ KDM4E B2RXH2 4/20 0.52
▸ GPR18 Q14330 2/20 0.48
▸ CNR1 P21554 1/20 0.48
▸ CNR2 P34972 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.44
▸ CA2 P00918 2/20 0.40
▸ CA1 P00915 1/20 0.38
▸ CLK1 P49759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26096057 1.00 MAPT (0.63) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL30363333 0.87 MAPT (0.58) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL26093496 0.87 MAPT (0.58) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL26095879 0.80 MAPT (0.56) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL26096202 0.80 MAPT (0.58) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL30363342 0.79 MAPT (0.57) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL26095459 0.79 MAPT (0.57) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL30363453 0.77 MAPT (0.62) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL26092928 0.77 MAPT (0.62) MAPTGAADYRK3PIM1CSNK2A2
SCHEMBL30145012 0.75 MAPT (0.56) MAPTGAADYRK3PIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422747-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072969-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback